Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dominique Farge

Showing results (111-120 of 192) with videos related to

Pageof 20
Sort By:
The Lancet. Oncology|September 8, 2019
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Corinne Frere, Jean M Connors, et al.
Bulletin Du Cancer|October 16, 2023
[Mobilization and conditioning protocols actualization for autologous stem cell transplantation for autoimmune diseases: Guidelines from MATHEC-SFGM-TC]Agnès Bonnin, Louis Terriou, Clément Beuvon, et al.
Bulletin Du Cancer|December 12, 2018
[Indications and follow-up for autologous hematopoietic stem cell transplantation in multiple sclerosis: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) in association with the Francophone Society of Multiple Sclerosis]Helène Zephir, Mathieu Puyade, Antoine Gueguen, et al.
Arthritis and Rheumatism|May 10, 2005
Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosisDominique Farge, Corneliu Henegar, Maryvonnick Carmagnat, et al.
Medicine|August 7, 2020
Pulmonary mucormycosis following autologous hematopoietic stem cell transplantation for rapidly progressive diffuse cutaneous systemic sclerosis: A case reportXavier Boumaza, Lucie Lelièvre, Sarah Guenounou, et al.
Frontiers in Oncology|November 8, 2021
Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMTTobias Alexander, John A Snowden, Joachim Burman, et al.
Cytotherapy|January 26, 2025
ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cellsKatarina Le Blanc, Francesco Dazzi, Karen English, et al.
Bulletin Du Cancer|December 11, 2019
[Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Mathieu Puyade, Céline Labeyrie, Manuela Badoglio, et al.
Critical Reviews in Oncology/Hematology|October 6, 2009
2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working groupDominique Farge, Lise Bosquet, Diana Kassab-Chahmi, et al.
Rheumatology (Oxford, England)|February 12, 2009
Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subsetJustyna M Rak, Philippe P Pagni, Kiet Tiev, et al.
Pageof 20

Showing results (111-120 of 192) with videos related to

Sort By:
Pageof 20
The Lancet. Oncology|September 8, 2019
2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancerDominique Farge, Corinne Frere, Jean M Connors, et al.
Bulletin Du Cancer|October 16, 2023
[Mobilization and conditioning protocols actualization for autologous stem cell transplantation for autoimmune diseases: Guidelines from MATHEC-SFGM-TC]Agnès Bonnin, Louis Terriou, Clément Beuvon, et al.
Bulletin Du Cancer|December 12, 2018
[Indications and follow-up for autologous hematopoietic stem cell transplantation in multiple sclerosis: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) in association with the Francophone Society of Multiple Sclerosis]Helène Zephir, Mathieu Puyade, Antoine Gueguen, et al.
Arthritis and Rheumatism|May 10, 2005
Analysis of immune reconstitution after autologous bone marrow transplantation in systemic sclerosisDominique Farge, Corneliu Henegar, Maryvonnick Carmagnat, et al.
Medicine|August 7, 2020
Pulmonary mucormycosis following autologous hematopoietic stem cell transplantation for rapidly progressive diffuse cutaneous systemic sclerosis: A case reportXavier Boumaza, Lucie Lelièvre, Sarah Guenounou, et al.
Frontiers in Oncology|November 8, 2021
Intestinal Microbiome in Hematopoietic Stem Cell Transplantation For Autoimmune Diseases: Considerations and Perspectives on Behalf of Autoimmune Diseases Working Party (ADWP) of the EBMTTobias Alexander, John A Snowden, Joachim Burman, et al.
Cytotherapy|January 26, 2025
ISCT MSC committee statement on the US FDA approval of allogenic bone-marrow mesenchymal stromal cellsKatarina Le Blanc, Francesco Dazzi, Karen English, et al.
Bulletin Du Cancer|December 11, 2019
[Indication of autologous stem cell transplantation in chronic inflammatory demyelinating polyneuropathy: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)]Mathieu Puyade, Céline Labeyrie, Manuela Badoglio, et al.
Critical Reviews in Oncology/Hematology|October 6, 2009
2008 French national guidelines for the treatment of venous thromboembolism in patients with cancer: report from the working groupDominique Farge, Lise Bosquet, Diana Kassab-Chahmi, et al.
Rheumatology (Oxford, England)|February 12, 2009
Male microchimerism and HLA compatibility in French women with sclerodema: a different profile in limited and diffuse subsetJustyna M Rak, Philippe P Pagni, Kiet Tiev, et al.
Pageof 20